NSEChange in Management30 Jun 2026 · 30 Jun 2026, 06:37 pm
Change in Management
Morepen Laboratories Limited · MOREPENLAB
✦ AI SummaryMgmt Change
Morepen Laboratories Limited has informed the Exchange about the elevation and change in designation of Mr. Sanjay Suri from Whole-time Director to Managing Director with effect from 1st July 2026, for the balance tenure of his existing term, i.e., up-to 12th August 2028.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Morepen Laboratories Limited has informed the Exchange about elevation and change in designation of Mr. Sanjay Suri
Attachments (1)
📄pdf
Download →
MOREPENLAB_30062026183730_Draft-SEIntimation30062026.pdf
View document text
Date: 30/06/2026
National Stock Exchange of India Ltd. BSE Limited
Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers,
Bandra (East), Mumbai- 400 051 Dalal Street, Mumbai- 400 001
Symbol: MOREPENLAB Scrip Code: 500288
Subject: Outcome of the meeting of the Board of Directors of the company
Ref.: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015 (“SEBI Listing Regulations”)
Dear Sir/Madam,
This is to inform you that, pursuant to the recommendation of the Nomination and Remuneration
Committee, the Board of Directors of the company, in their meeting held on Tuesday, 30th June
2026 (commenced at 05.00 p.m. and concluded at 6.15 p.m.), have, inter-alia, considered and
approved the elevation and change in designation of Mr. Sanjay Suri (DIN: 00041590) from
‘Whole-time Director’ to ‘Managing Director’ with effect from 1st July 2026, for the balance tenure
of his existing term, i.e., up-to 12th August 2028, subject to the approval of members of the company
within the prescribed statutory timelines.
Consequent upon his elevation and change in designation as the Managing Director of the
Company, Mr. Sanjay Suri will jointly oversee the management and operations of the Company
with Mr. Sushil Suri, Chairman & Managing Director, with clearly defined roles and
responsibilities aligned to their respective areas of expertise.
The details as required under the SEBI Listing Regulations read with SEBI master Circular no.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026, is given in the Annexure.
You are requested to take the same on record.
Thanking you,
Yours faithfully,
For Morepen Laboratories Limited
Vipul Kumar Srivastava
Company Secretary
F-12148
Encl.: a/a.
Morepen Laboratories Limited
CIN NO. L24231 HP1984PLC006028
Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA
TEL.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com
Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA
Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: plants@morepen.com
Annexure
Disclosure in terms of Regulation 30 read with SEBI master Circular No.
HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated 30th January 2026
S. no. Particulars Details
1. Reason for change viz. Elevation and change in designation of Mr. Sanjay
appointment, re-appointment, Suri (DIN: 00041590) from Whole-time Director
resignation, removal, death or
to the Managing Director.
otherwise;
2. Date of appointment/re- Date of appointment: 1st July 2026
appointment/cessation (as
applicable) & term of Term of appointment: Based on the
appointment/re-appointment; recommendation of the Nomination and
Remuneration Committee, the Board has approved
the elevation and change in designation of Mr.
Sanjay Suri from Whole-time Director to the
Managing Director with effect from 1st July 2026,
for the balance tenure of his existing term, i.e., up-
to 12th August 2028, subject to the approval of
members the company within the prescribed
statutory timelines.
3. Brief profile (in case of Mr. Sanjay Suri is a Bachelor of Science (B.Sc.),
appointment); having more than thirty years of experience in
pharmaceuticals industry.
He has varied experience in the field of
international sales and marketing, joint ventures,
statutory and regulatory approvals (including
USFDA), strategic planning, manufacturing
operations, including finance, accounts and
banking.
4. Disclosure of relationships Mr. Sanjay Suri is a member of promoter group of
between directors (in case of the company and brother of Mr. Sushil Suri,
appointment of a director);
Chairman and Managing Director & Promoter of
the company.
5. Other information Mr. Sanjay Suri is not debarred from holding the
office of the Managing Director by virtue of any
order passed by the SEBI or any other such
authority.
Morepen Laboratories Limited
CIN NO. L24231 HP1984PLC006028
Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA
TEL.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com
Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA
Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: plants@morepen.com